Staritas ads

Clinical differentiation can strengthen a product's value proposition. It does not automatically create a compelling business case for adoption. Customers are evaluating more than clinical performance. They are weighing pricing, economic impact, operational fit, and comparative value against products they already know and use. When that broader value is unclear, even meaningful innovation can struggle to move beyond initial interest. In our latest article, Why Innovation Fails to Convert into Market Share, we explore the gap between creating product value and translating that value into market traction. You’ll gain insight into: - Why clinical differentiation may not be enough to drive adoption - How pricing and economic value influence market traction - Why positioning innovation relative to alternatives matters for growth 👉 Read Article

Webinar | October 8, 2026 12:00 p.m. ET Make every capital decision count What can you take back to your organization after one hour? Hear how healthcare leaders are approaching some of the hardest questions in capital planning: · How do you prioritize when multiple investments can be justified? · When should equipment be replaced, repaired, or deferred? · How do you balance clinical, operational, and financial priorities? · How do you build support around difficult choices? Get practical perspectives from supply chain leaders at Jackson Health System, Seattle Children’s, and Advocate Health. October 8 | 12–1 p.m. ET Reserve your spot.

When adoption falls short of expectations, sales execution is often one of the first places organizations look. But slower growth does not always mean the issue starts—or ends—with Sales. Pricing may be misaligned with market expectations. Customers may not see enough comparative value to switch. Established competitors may be protected by contracts, workflows, and familiarity. The challenge is understanding what is actually limiting traction before deciding how to respond. Our latest article, Why Innovation Fails to Convert into Market Share, examines why product performance and commercial performance can tell very different stories. Read more about: - What may be limiting adoption beyond sales execution - Why competitive inertia can slow otherwise strong products - How pricing, positioning, and market dynamics influence commercial traction 👉Read Article

Take a broader view of equipment replacement The oldest equipment isn’t always the equipment that needs to be replaced first. What else should factor into the decision? Hear how supply chain leaders from Jackson Health System, Seattle Children’s, and Advocate Health approach equipment replacement, competing priorities, portfolio needs, and the difficult decisions behind the capital plan. October 8 | 12–1 p.m. ET See how leaders are looking beyond equipment age.

Customers need a reason to switch, not simply a better alternative. Customers weigh a new product against what they already use— what it costs, how it fits existing workflows, and whether changing is worth the disruption. A product can be clinically differentiated and still face resistance if its comparative and economic value is not strong enough to justify the switch. This Staritas article, Why Innovation Fails to Convert into Market Share, explores what manufacturers can miss when strong products encounter unexpected resistance in the market. Take a closer look at: - Why clinical differentiation does not always translate into customer adoption - What established alternatives have working in their favor - How comparative value and pricing can influence the decision to switch 👉 Read Article

New customer wins are an important signal of traction. But they do not always show how broadly a product is gaining ground. Growth may be concentrated in a small number of accounts while significant market opportunity remains untapped. Without a broader view of utilization, individual wins don’t reveal where a product is gaining share, where adoption is lagging, or where additional opportunities may exist. Our latest article, Why Innovation Fails to Convert into Market Share, explores why adoption visibility matters when turning early success into sustained growth. Read more about: - Why individual wins may not reflect broader market penetration - How utilization visibility can reveal where adoption is strong or lagging - Why understanding adoption patterns can help identify where to focus next 👉 Read Article